Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
124.30
-2.65 (-2.09%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Novo Nordisk Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 140, with a low estimate of 115 and a high estimate of 160. The average target predicts an increase of 12.63% from the current stock price of 124.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +28.72% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +28.72% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +28.72% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +28.72% | Aug 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $170 → $160 | Buy | Maintains | $170 → $160 | +28.72% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
293.23B
from 232.26B
Increased by 26.25%
Revenue Next Year
354.66B
from 293.23B
Increased by 20.95%
EPS This Year
23.21
from 18.62
Increased by 24.66%
EPS Next Year
29.50
from 23.21
Increased by 27.09%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 313.4B | 394.4B | 486.9B | ||
| Avg | 293.2B | 354.7B | 416.0B | ||
| Low | 278.0B | 313.3B | 350.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.9% | 34.5% | 37.3% | ||
| Avg | 26.2% | 21.0% | 17.3% | ||
| Low | 19.7% | 6.9% | -1.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.66 | 33.90 | 42.54 | ||
| Avg | 23.21 | 29.50 | 35.56 | ||
| Low | 21.27 | 25.43 | 28.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 37.8% | 46.1% | 44.2% | ||
| Avg | 24.7% | 27.1% | 20.5% | ||
| Low | 14.2% | 9.6% | -2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.